Concepedia

Hans Vandekerckhove

HV

Statistics

Publications

12

Citations

1.4K

H-Index

11

Active since

1993

Affiliations

AZ Sint-Lucas(Current)

Brigham and Women's Hospital

Harvard University

University of Groningen

University of Glasgow

Hans Vandekerckhove is an author at AZ Sint-Lucas specializing in medicine, cardiology, and heart failure.

Publications per year

1993–2024

12

Publications

12

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

John R. Teerlink, Rafael Díaz, G. Michael Felker et al. · New England Journal of Medicine · 2020 · 644 citations · Full text

, , +15

Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial

John R. Teerlink, G. Michael Felker, John J.V. McMurray et al. · The Lancet · 2016 · 293 citations · Full text

, , +10

Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction

Burkert Pieske, Rolf Wachter, Sanjiv J. Shah et al. · JAMA · 2021 · 161 citations · Full text

, , +14

Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study

Kausik K. Ray, Carlos Aguíar, Marcello Arca et al. · European Journal of Preventive Cardiology · 2024 · 70 citations · Full text

, , +17

Omecamtiv Mecarbil in Chronic Heart Failure with Reduced Ejection Fraction: GALACTIC-HF Baseline Characteristics and Comparison with Contemporary Clinical Trials

John R. Teerlink, Rafael Díaz, G. Michael Felker et al. · European Journal of Heart Failure · 2020 · 65 citations · Full text

, , +16

1–5 of 12